MY ACCOUNT | NEWSLETTER |

Management of medial luxation of the shoulder joint in toy-breed dogs using an antiluxation pin placed lateral to the supraspinatus muscle tendon: 20 limbs (2017–2022)


Objective: To describe the clinical and diagnostic findings, surgical procedures, and clinical course of dogs with medial shoulder luxation (MSL) treated with a novel method using an antiluxation pin.

Animals: 18 client-owned toy-breed dogs (20 treated limbs).

Clinical presentation: Toy-breed dogs with MSL were treated with the antiluxation pin (2017 to 2022). The collected data included signalment, cause of luxation, preoperative and follow-up clinical evaluations with lameness scores (LMS), and radiographic and/or CT findings.

Results: Toy Poodle was the most represented breed (17 of 18 dogs [94.4%]). The median age was 10 years. One of 18 dogs had a history of trauma. Medial luxation was confirmed in all limbs using radiography or palpation under general anesthesia. Reluxation occurred in 3 limbs at 1, 4, and 30 days after surgery, respectively. Of these 3 limbs, 1 limb underwent revision to replace the original pin and the other 2 limbs underwent no further treatment. One limb with persistent pain underwent 2 revision surgeries to adjust the pin orientation 30 and 72 days after the initial surgery. Eighteen limbs remained unluxated after the initial or revision surgery until the final follow-up (median, 18.5 months; range, 1 to 63 months). The LMS at the final follow-up for the 18 unluxated limbs (mean, 0.5) was significantly lower than the preoperative LMS (mean, 4.5) (P < .01).

Clinical relevance: A novel method of the antiluxation pin provides an alternative surgical treatment for MSL in toy-breed dogs that is minimally invasive and technically simple.


Authors: Takeshi Aikawa, Shuya Kihara, Yuta Miyazaki, Hiromi Muyama, Masaaki Nishimura

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Penn Vet Announces Interim Leadership for the Department of Clinical Sciences and Advanced Medicine, and Ryan Hospital

Like0
Dislike0

Parnell Launches nixiFLOR® - First FDA-Approved Generic Florfenicol + Flunixin Combination for BRD

Like0
Dislike0

Comparison of two host cell range variants of feline immunodeficiency virus

Like0
Dislike0

Canine babesiosis: a perspective on clinical complications, biomarkers, and treatment

Like0
Dislike0

The use of growth promoters in swine nutrition: Problems and perspectives concerning public health and swine production

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top